MWNA
FPRX

Marshall Wace North America’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Marshall Wace North America’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-67,575
Closed -$2.77M – 1708
2017
Q3 		$2.77M Sell
67,575
-273,812
-80% -$11.2M 0.02% 708
2017
Q2 		$10.2M Buy
341,387
+56,058
+20% +$1.68M 0.07% 311
2017
Q1 		$10.3M Buy
+285,329
New +$10.3M 0.08% 260
2013
Q4 		$314K Buy
+18,700
New +$314K 0.01% 595